BAPO
ActiveSummary
The computed 12-month bankruptcy probability of BAPO is 2.4% (moderate). The 2024 annual accounts show negative equity (-€654,091) and a net result of -€46,349. Equity is shrinking by about 34% per year across the filed financial years. Its solvency ranks better than 8% of 674 sector peers (NACE 55, financial year 2024). The company has been active since 1983 and the Belgian Official Gazette contains no insolvency or warning signals.
History
Acts, filings and financial milestones
18-01
Gazette deed
Resignations: DEHING Cecile Isidore Nelly Antonia, LUCA Max Robert Gerrit and PHARMA FINANCEAppointment: PHARMA FINANCE (director) · Permanent representative: LUCA Max Robert Gerrit · Amendment of the articles11 facts ▸
- General meeting, “buitengewone algemene vergadering van de aandeelhouders” (deed in Dutch)
- Amendment of the articles (2 times)
- Capital conversion, “van rechtswege omgezet, Tweede besluit vaststelling” (deed in Dutch)
- Reserve release, “opheffing en beschikbaar maken voor uitkering, statutair onbeschikbare eigen vermogensrekening” (deed in Dutch)
- Director resignation, DEHING Cecile Isidore Nelly Antonia (manager and director)
- Director resignation, LUCA Max Robert Gerrit (manager and director)
- Director resignation, PHARMA FINANCE (manager and director)
- Director appointment, PHARMA FINANCE (director (not named in the articles))
- Permanent representative, LUCA Max Robert Gerrit
- Other provision, “kwijting ontslagnemende zaakvoerders/bestuurders, volgende jaarvergadering” (deed in Dutch)
- Registered office clause, “3140 Keerbergen,Mereldreef 37” (deed in Dutch)
About the unread acts
Of the 5 Belgian Official Gazette deeds we know for this company, 1 has been read. The other 4 have not been read yet: what they contain is neither established nor disproved here.